 |
인쇄하기
취소
|
CrystalGenomics buys Hwail for 46.8 billion won
Korea’s emerging biotech company CrystalGenomics Inc. said Tuesday it reached a deal to buy Hwail Pharm, a pharmaceutical raw material manufacturer, for 46.8 billion won.
The stock purchase agreement calls for the takeover of a 21.66 percent stake in Hwail currently owned by Hwail’s two largest shareholders chairman Lee Joung-kyu (15.47 percent stake) and CEO Lee Lee Phil-joon (16.1 percent ...
The stock purchase agreement calls for the takeover of a 21.66 percent stake in Hwail currently owned by Hwail’s two largest shareholders chairman Lee Joung-kyu (15.47 percent stake) and CEO Lee Lee Phil-joon (16.1 percent ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.